PART I ITEM 1. Description of Business Overview Telomir Pharmaceuticals, Inc. is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. Our research strategy targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mit...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001493152-26-010625 | EDGAR | 51K words |
| 2025-02-04 | 2024-12-31 | 0001493152-25-004872 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001493152-24-012049 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001493152-25-021496 | EDGAR | 15K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023970 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010298 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044749 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031606 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018909 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001493152-26-036742 | EDGAR | — |
| 2026-03-31 | 0001493152-26-013872 | EDGAR | 0K words |
| 2026-03-31 | 0001493152-26-013785 | EDGAR | — |
| 2026-03-27 | 0001493152-26-013240 | EDGAR | — |
| 2026-02-17 | 0001493152-26-006937 | EDGAR | — |
| 2026-02-05 | 0001493152-26-005199 | EDGAR | — |
| 2026-01-12 | 0001493152-26-001170 | EDGAR | — |
| 2026-01-05 | 0001493152-26-000267 | EDGAR | — |
| 2025-12-22 | 0001493152-25-028620 | EDGAR | — |
| 2025-12-17 | 0001493152-25-028126 | EDGAR | — |
69 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001971532 |
| Ticker | TELO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | FL |
| Website | https://www.telomirpharma.com |
| Listed | 2024-02-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TELO (~200 tokens, structured JSON with cryptographic provenance)